Skip to Content

955 Results Found

  • Article
  • Open Access
2 Citations
4,392 Views
11 Pages

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors

  • Dina Ibrahim,
  • Léa Prévaud,
  • Nathalie Faumont,
  • Danielle Troutaud,
  • Jean Feuillard,
  • Mona Diab-Assaf and
  • Ahmad Oulmouden

16 June 2022

While studying c-Myc protein expression in several Burkitt lymphoma cell lines and in lymph nodes from a mouse model bearing a translocated c-MYC gene from the human BL line IARC-BL60, we surprisingly discovered a complex electrophoretic profile. Ind...

  • Review
  • Open Access
74 Citations
13,152 Views
20 Pages

19 April 2017

Over 35 years ago, c-MYC, a highly pleiotropic transcription factor that regulates hepatic cell function, was identified. In recent years, a considerable increment in the number of publications has significantly shifted the way that the c-MYC functio...

  • Review
  • Open Access
8 Citations
4,036 Views
16 Pages

15 December 2023

The transcription factor c-Myc, a key regulator of cellular processes, has long been associated with roles in cell proliferation and apoptosis. This review analyses the multiple functions of c-Myc by examining the different c-Myc isoforms in detail....

  • Article
  • Open Access
11 Citations
4,258 Views
23 Pages

c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer

  • Martina Lepore Signorile,
  • Valentina Grossi,
  • Candida Fasano,
  • Giovanna Forte,
  • Vittoria Disciglio,
  • Paola Sanese,
  • Katia De Marco,
  • Francesca La Rocca,
  • Raffaele Armentano and
  • Cristiano Simone
  • + 2 authors

4 October 2022

c-MYC is one of the most important factors involved in colorectal cancer (CRC) initiation and progression; indeed, it is found to be upregulated in up to 80% of sporadic cases. During colorectal carcinogenesis, c-MYC is maintained upregulated through...

  • Review
  • Open Access
155 Citations
18,547 Views
23 Pages

5 April 2017

c-MYC is one of the most essential transcriptional factors, regulating a diverse array of cellular functions, including proliferation, growth, and apoptosis. Dysregulation of c-MYC is essential in the pathogenesis of a number of B-cell lymphomas, but...

  • Review
  • Open Access
52 Citations
4,758 Views
28 Pages

Targeting c-MYC G-Quadruplexes for Cancer Treatment with Small Molecules

  • Prasanth Thumpati,
  • Sachchida Nand Rai,
  • Chandrabhan Prajapati,
  • Kakarla Ramakrishna and
  • Santosh Kumar Singh

Novel therapies are required due to the rising cancer burden. Conventional chemotherapeutics tend to be particularly toxic, but there is a promising alternative for oncogenes, such as c-MYC. Often overexpressed in many cancer types, the potential c-M...

  • Article
  • Open Access
5 Citations
3,132 Views
17 Pages

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL). Elevated expression of c-MYC in DLBCL is associated with poor prognosis of the disease. In different cancers, c-MYC has been found regulated by diffe...

  • Article
  • Open Access
64 Citations
5,769 Views
18 Pages

c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors

  • Antonia Strippoli,
  • Alessandra Cocomazzi,
  • Michele Basso,
  • Tonia Cenci,
  • Riccardo Ricci,
  • Francesco Pierconti,
  • Alessandra Cassano,
  • Vincenzo Fiorentino,
  • Carlo Barone and
  • Maurizio Martini
  • + 4 authors

10 March 2020

Alterations in the transcriptional factor c-MYC could be involved in the anti-EGFR resistance in metastatic colorectal cancer (mCRC). The c-MYC expression was evaluated in 121 RAS and BRAF wild-type mCRC before treatment with anti-EGFR+Folfiri therap...

  • Article
  • Open Access
4 Citations
3,514 Views
17 Pages

Estrogen Induces c-myc Transcription by Binding to Upstream ERE Element in Promoter

  • Nazia Rehman,
  • Shahrukh Khan,
  • Shumaila Manzoor,
  • Muhammad Abubakar,
  • Rokayya Sami,
  • Saif A. Alharthy,
  • Roua S. Baty,
  • Ibrahim Jafri,
  • Nouf H. Alsubhi and
  • Ramla Shahid
  • + 1 author

6 July 2022

Estrogen Receptor α(ERα) is reported to regulate the expression of many target genes by binding to specific estrogen response elements (EREs) in their promoters. c-myc is known to be over-expressed in most of the human carcinomas due to d...

  • Article
  • Open Access
32 Citations
4,867 Views
22 Pages

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis

  • Jiaoyuan Jia,
  • Li Che,
  • Antonio Cigliano,
  • Xue Wang,
  • Graziella Peitta,
  • Junyan Tao,
  • Sheng Zhong,
  • Silvia Ribback,
  • Matthias Evert and
  • Diego F. Calvisi
  • + 1 author

11 November 2020

Hepatocellular carcinoma (HCC) is a deadly form of liver malignancy with limited treatment options. Amplification and/or overexpression of c-MYC is one of the most frequent genetic events in human HCC. The mammalian target of Rapamycin Complex 1 (mTO...

  • Article
  • Open Access
113 Views
14 Pages

Stability of c-Myc Protein in Early S Phase Is Regulated by the Interaction with PCNA

  • Miriana Cardano,
  • Ornella Cazzalini,
  • Giusy Maraventano,
  • Lucia A. Stivala,
  • Laura Zannini and
  • Ennio Prosperi

The transcription factor c-Myc is known to regulate DNA replication via a non-transcriptional mechanism by interacting with proteins of the pre-replicative complex. In addition, c-Myc localizes to DNA replication foci, similarly to Proliferating Cell...

  • Article
  • Open Access
8 Citations
3,685 Views
20 Pages

Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC

  • Shannon E. Moree,
  • Laure Maneix,
  • Polina Iakova,
  • Fabio Stossi,
  • Ergun Sahin and
  • Andre Catic

4 February 2022

The ubiquitin–proteasome pathway precisely controls the turnover of transcription factors in the nucleus, playing an important role in maintaining appropriate quantities of these regulatory proteins. The transcription factor c-MYC is essential...

  • Article
  • Open Access
1 Citations
2,957 Views
11 Pages

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study

  • Fiona Turkes,
  • Annette Bryant,
  • Ruwaida Begum,
  • Michael Davidson,
  • Eleftheria Kalaitzaki,
  • Maria Aresu,
  • Retchel Lazaro-Alcausi,
  • Jane Bryant,
  • Isma Rana and
  • Ian Chau
  • + 9 authors

22 March 2022

Oesophagogastric (OG) cancer is a highly lethal disease requiring novel treatment options. c-MYC and/or HER-2 amplified oesophageal cancer models have demonstrated sensitivity to BTK inhibition with ibrutinib. We evaluated the safety and efficacy of...

  • Review
  • Open Access
24 Citations
5,681 Views
48 Pages

Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells

  • Cristina Trejo-Solís,
  • Rosa Angélica Castillo-Rodríguez,
  • Norma Serrano-García,
  • Daniela Silva-Adaya,
  • Salvador Vargas-Cruz,
  • Elda Georgina Chávez-Cortéz,
  • Juan Carlos Gallardo-Pérez,
  • Sergio Zavala-Vega,
  • Arturo Cruz-Salgado and
  • Roxana Magaña-Maldonado

25 April 2024

The metabolic reprogramming that promotes tumorigenesis in glioblastoma is induced by dynamic alterations in the hypoxic tumor microenvironment, as well as in transcriptional and signaling networks, which result in changes in global genetic expressio...

  • Article
  • Open Access
6 Citations
2,683 Views
13 Pages

c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway

  • Maria Anele Romeo,
  • Maria Saveria Gilardini Montani,
  • Andrea Arena,
  • Rossella Benedetti,
  • Gabriella D’Orazi and
  • Mara Cirone

It has been shown that wild-type (wt)p53 inhibits oncogene c-Myc while mutant (mut)p53 may transactivate it, with an opposite behavior that frequently occurs in the crosstalk of wt or mutp53 with molecules/pathways promoting carcinogenesis. Even if i...

  • Article
  • Open Access
384 Views
16 Pages

Gene Expression and Immunohistochemical Analyses of c-Myc in Canine and Feline Soft Tissue Fibrosarcomas

  • Waseem Al-Jameel,
  • Ahmad Al-Saidya,
  • Baidaa Salah,
  • Hana Ismail and
  • Saevan Al-Mahmood

12 February 2026

Canine and feline fibrosarcomas are malignant tumors of mesenchymal origin showing histological, molecular, and clinical structures similar to their human equivalent. In human medicine, cellular myelocytomatosis (c-Myc) has already been proposed as a...

  • Article
  • Open Access
17 Citations
5,413 Views
11 Pages

Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer

  • Gulnur K. Zakiryanova,
  • Elena Kustova,
  • Nataliya T. Urazalieva,
  • Emile T. Baimuchametov,
  • Narymzhan N. Nakisbekov and
  • Michael R. Shurin

11 February 2019

Natural killer (NK) cells have received a lot of attention in recent years for the roles they play in immunity and particularly in antitumor immune responses. Although defects in NK cell functions are recognized as important mechanisms for immune eva...

  • Article
  • Open Access
8 Citations
2,309 Views
10 Pages

Apoptotic Effect of Isoimpertorin via Inhibition of c-Myc and SIRT1 Signaling Axis

  • Hwan-Joo Ko,
  • Su-Yeon Park,
  • Deok Yong Sim,
  • Sung-Hoon Kim,
  • Soyoung Hur,
  • Jang-Hoon Lee and
  • Youngchul Kim

Though Isoimperatorin from Angelicae dahuricae is known to have antiviral, antidiabetic, anti-inflammatory and antitumor effects, its underlying antitumor mechanism remains elusive so far. Hence, the apoptotic mechanism of Isoimperatorin was explored...

  • Article
  • Open Access
17 Citations
4,229 Views
28 Pages

Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells

  • Min Zhou,
  • Joelle C. Boulos,
  • Ejlal A. Omer,
  • Sabine M. Klauck and
  • Thomas Efferth

26 July 2023

The c-MYC oncogene regulates multiple cellular activities and is a potent driver of many highly aggressive human cancers, such as leukemia and triple-negative breast cancer. The oxadiazole class of compounds has gained increasing interest for its ant...

  • Review
  • Open Access
3 Citations
2,086 Views
15 Pages

c-Myc and FOXO3a—The Everlasting Decision Between Neural Regeneration and Degeneration

  • Andrey M. Khaitin,
  • Valeria V. Guzenko,
  • Stanislav S. Bachurin and
  • Svetlana V. Demyanenko

24 November 2024

The transcription factors c-Myc and FoxO3a play significant roles in neurodegenerative processes, yet their interaction in neurological disorders remains largely unexplored. In contrast, much of the available information about their relationship come...

  • Article
  • Open Access
36 Citations
6,369 Views
15 Pages

Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc

  • Ching-Yu Lin,
  • Bi-Juan Wang,
  • Bo-Chih Chen,
  • Jen-Chih Tseng,
  • Shih Sheng Jiang,
  • Kelvin K. Tsai,
  • Ying-Ying Shen,
  • Chiou Hwa Yuh,
  • Zong-Lin Sie and
  • Chih-Pin Chuu
  • + 2 authors

13 November 2019

Our three-dimensional organotypic culture revealed that human histone demethylase (KDM) 4C, a histone lysine demethylase, hindered the acini morphogenesis of RWPE-1 prostate cells, suggesting its potential oncogenic role. Knockdown (KD) of KDM4C supp...

  • Feature Paper
  • Article
  • Open Access
1 Citations
2,743 Views
16 Pages

Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer

  • Sofia Henriksson,
  • José Manuel Calderón-Montaño,
  • Daniel Solvie,
  • Ulrika Warpman Berglund and
  • Thomas Helleday

29 November 2022

Previously, we reported that MTH1 inhibitors TH588 and TH1579 selectively induce oxidative damage and kill Ras-expressing or -transforming cancer cells, as compared to non-transforming immortalized or primary cells. While this explains the impressive...

  • Article
  • Open Access
25 Citations
3,645 Views
14 Pages

C-Myc Expression in Oral Squamous Cell Carcinoma: Molecular Mechanisms in Cell Survival and Cancer Progression

  • Guya Diletta Marconi,
  • Ylenia Della Rocca,
  • Luigia Fonticoli,
  • Francesco Melfi,
  • Thangavelu Soundara Rajan,
  • Simone Carradori,
  • Jacopo Pizzicannella,
  • Oriana Trubiani and
  • Francesca Diomede

Oral squamous cell carcinoma (OSCC) represents 90% of malignant epithelial cancer that occurs in the oral cavity. The c-Myc factor is expressed in multiple types of cancer, comprising head and neck squamous cell carcinoma (HNSCC), where it plays a fu...

  • Article
  • Open Access
2,228 Views
9 Pages

Clinical Differences in c-Myc Expression in Early-Stage Gastric Neoplasia: A Retrospective Study Based on the WHO Classification

  • Noriyuki Arakawa,
  • Atsushi Irisawa,
  • Kazuyuki Ishida,
  • Takuya Tsunoda,
  • Yoshiko Yamaguchi,
  • Goro Shibukawa,
  • Makoto Eizuka,
  • Shunzo Tokioka and
  • Hiroto Wakabayashi

21 January 2022

c-Myc is an oncogene that is dysregulated in various cancers. Early gastric neoplasia with c-Myc expression has been reported as a more malignant lesion. This study clarifies the differences in c-Myc expression in early gastric neoplasia based on the...

  • Article
  • Open Access
8 Citations
2,672 Views
14 Pages

Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC

  • Xia Zhang,
  • Peng Peng,
  • Li-Wei Bao,
  • An-Qi Zhang,
  • Bo Yu,
  • Tao Li,
  • Jing Lei,
  • Hui-Hui Zhang and
  • Shang-Ze Li

30 October 2024

Background: Ubiquitination is an important post-transcriptional modification crucial for maintaining cell homeostasis. As a deubiquitination enzyme, ubiquitin-specific protease 1 (USP1) is associated with tumor progression; however, its role in bladd...

  • Article
  • Open Access
7 Citations
3,439 Views
23 Pages

Phenformin Down-Regulates c-Myc Expression to Suppress the Expression of Pro-Inflammatory Cytokines in Keratinocytes

  • Guanyi Liu,
  • Dingyang Li,
  • Liwei Zhang,
  • Qiuping Xu,
  • Dexuan Zhuang,
  • Panpan Liu,
  • Ling Hu,
  • Huiting Deng,
  • Jianfeng Sun and
  • Xunwei Wu
  • + 3 authors

5 August 2022

The treatment of many skin inflammation diseases, such as psoriasis and atopic dermatitis, is still a challenge and inflammation plays important roles in multiple stages of skin tumor development, including initiation, promotion and metastasis. Phenf...

  • Communication
  • Open Access
14 Citations
4,803 Views
11 Pages

HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma

  • Hiroyuki Tsuchiya,
  • Masataka Amisaki,
  • Ai Takenaga,
  • Soichiro Honjo,
  • Yoshiyuki Fujiwara and
  • Goshi Shiota

14 November 2019

Unconventional prefoldin RNA polymerase II subunit 5 interactor (URI1) has emerged as an oncogenic driver in hepatocellular carcinoma (HCC). Although the hepatitis B virus (HBV) represents the most common etiology of HCC worldwide, it is unknown whet...

  • Article
  • Open Access
13 Citations
3,381 Views
12 Pages

Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells

  • Andrea Arena,
  • Maria Anele Romeo,
  • Rossella Benedetti,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone

Multiple myeloma (MM) and primary effusion lymphoma (PEL) are aggressive hematological cancers, for which the search for new and more effective therapies is needed. Both cancers overexpress c-Myc and are highly dependent on this proto-oncogene for th...

  • Article
  • Open Access
4 Citations
1,959 Views
21 Pages

Exploring the Interaction of New Pyridoquinazoline Derivatives with G-Quadruplex in the c-MYC Promoter Region

  • Salvatore Princiotto,
  • Maria Karelou,
  • Rachel Ioannidi,
  • Giovanni Luca Beretta,
  • Nadia Zaffaroni,
  • Roberto Artali,
  • Ioannis K. Kostakis,
  • Stefania Mazzini and
  • Sabrina Dallavalle

20 September 2023

Novel amino-substituted pyridoquinazolinone derivatives have been designed and synthesized as potential c-MYC G-quadruplex (G4) ligands, employing an efficient methodology. All the new compounds exhibited moderate to good antiproliferative activity a...

  • Article
  • Open Access
4 Citations
4,015 Views
25 Pages

Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

  • Ye Yuan,
  • Mohammad Alzrigat,
  • Aida Rodriguez-Garcia,
  • Xueyao Wang,
  • Tomas Sjöberg Bexelius,
  • John Inge Johnsen,
  • Marie Arsenian-Henriksson,
  • Judit Liaño-Pons and
  • Oscar C. Bedoya-Reina

16 September 2023

Deregulation of the MYC family of transcription factors c-MYC (encoded by MYC), MYCN, and MYCL is prevalent in most human cancers, with an impact on tumor initiation and progression, as well as response to therapy. In neuroblastoma (NB), amplificatio...

  • Article
  • Open Access
6 Citations
3,143 Views
15 Pages

RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway

  • Jie Xu,
  • Pengfei Shi,
  • Fanwei Xia,
  • Xuan Zhao,
  • Junfan Chen,
  • Rui Geng,
  • Hongjuan Cui and
  • Liqun Yang

10 October 2022

Melanoma originates from the malignant transformation of melanocytes. Compared with other skin cancers, melanoma has a higher fatality rate. The 5-year survival rate of patients with early-stage primary melanoma through surgical resection can reach m...

  • Article
  • Open Access
2 Citations
2,686 Views
20 Pages

Docosahexaenoic Acid Inhibits Cell Proliferation through a Suppression of c-Myc Protein in Pancreatic Ductal Adenocarcinoma Cells

  • Jia-Ning Syu,
  • Der-Yen Lee,
  • Hung-Chang Hung,
  • Chia-Ying Li,
  • Hung-Yu Lin,
  • En-Pei Isabel Chiang,
  • Yi-Heng Chen,
  • Shu-Ming Huang and
  • Feng-Yao Tang

28 October 2021

Treatment of pancreatic cancer by inhibiting the aberrant activation of the survival signaling pathways has received considerable attention. We investigated the probable action of DHA on the suppression of cell proliferation in human pancreatic ducta...

  • Article
  • Open Access
7 Citations
2,744 Views
16 Pages

Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer

  • Wenhua Huang,
  • Qin Chen,
  • Yali Lu,
  • Zhe Kong,
  • Xuechao Wan,
  • Yan Huang,
  • Minyan Qiu and
  • Yao Li

13 October 2022

Long noncoding RNAs (lncRNAs) have been found as novel participants in the pathophysiology of prostate cancer (PCa), which is predominantly regulated by androgen and its receptor. The biological function of androgen-responsive lncRNAs remains poorly...

  • Article
  • Open Access
16 Citations
4,311 Views
17 Pages

c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma

  • Pie-Che Chen,
  • Chih-Chia Yu,
  • Wen-Yu Huang,
  • Wan-Hong Huang,
  • Yu-Ming Chuang,
  • Ru-Inn Lin,
  • Jora M. J. Lin,
  • Hon-Yi Lin,
  • Yeong-Chin Jou and
  • Michael W. Y. Chan
  • + 1 author

28 September 2019

MicroRNAs (miRNAs) have been shown to play a crucial role in the progression of human cancers, including urothelial carcinoma (UC), the sixth-most common cancer in the world. Among them, miR-34a has been implicated in the regulation of cancer stem ce...

  • Article
  • Open Access
3 Citations
2,634 Views
25 Pages

Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells

  • Ana Laura S. A. Matos,
  • Ashley J. Ovens,
  • Emil Jakobsen,
  • Diego Iglesias-Gato,
  • Jacob M. Bech,
  • Stine Friis,
  • Lasse Kristoffer Bak,
  • Gunvor I. Madsen,
  • Jonathan S. Oakhill and
  • José M. A. Moreira
  • + 1 author

17 February 2025

Aspirin has consistently shown preventive effects in some solid cancers, notably colorectal cancer. However, the precise molecular mechanisms underlying this positive effect have remained elusive. In this study, we used an azoxymethane-induced mouse...

  • Article
  • Open Access
40 Citations
10,802 Views
20 Pages

11 October 2013

Acidosis is a biochemical hallmark of the tumor microenvironment. Here, we report that acute acidosis decreases c-Myc oncogene expression in U937 human lymphoma cells. The level of c-Myc transcripts, but not mRNA or protein stability, contributes to...

  • Review
  • Open Access
210 Citations
19,498 Views
16 Pages

Myc is a nuclear transcription factor that mainly regulates cell growth, cell cycle, metabolism, and survival. Myc family proteins contain c-Myc, n-Myc, and l-Myc. Among them, c-Myc can become a promising therapeutic target molecule in cancer. Cancer...

  • Article
  • Open Access
5 Citations
3,640 Views
14 Pages

15 August 2022

MYC has a short half-life that is tightly regulated through phosphorylation and proteasomal degradation. Many studies have claimed that treatment with disulfiram (DSF) with or without copper ions can cause cancer cell death in a reactive oxygen speci...

  • Article
  • Open Access
3 Citations
1,764 Views
12 Pages

RNA-Binding Motif Protein 22 Induces Apoptosis via c-Myc Pathway in Colon Cancer Cells

  • Ye-Rin Park,
  • So-Mi Park,
  • Nanyeong Kim,
  • Jihoon Jung,
  • Seokwoo Kim,
  • Kwan-Il Kim and
  • Hyeung-Jin Jang

RNA-binding motif 22 (RBM22) is an RNA-binding protein involved in gene regulation, with the capacity to bind DNA and function as a transcription factor for various target genes. Recent studies demonstrated that RBM22 depletion affects cell viability...

  • Article
  • Open Access
30 Citations
7,851 Views
13 Pages

Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

  • Yueh-Chun Lee,
  • Wen-Wei Chang,
  • Yi-Ying Chen,
  • Yu-Hung Tsai,
  • Ying-Hsiang Chou,
  • Hsien-Chun Tseng,
  • Hsin-Lin Chen,
  • Chun-Chieh Wu,
  • Ju Chang-Chien and
  • Bing-Yen Wang
  • + 2 authors

15 September 2017

Heat shock protein 90 (Hsp90) is a molecular chaperone that facilitates the correct folding and functionality of its client protein. Numerous Hsp90-client proteins are involved in cancer development. Thus, Hsp90 inhibitors have potential applications...

  • Article
  • Open Access
1,476 Views
11 Pages

Glutamine metabolism is essential for infectious spleen and kidney necrosis virus (ISKNV) replication. Glutaminase 1 (GLS1), the key enzyme of the glutamine metabolism, and c-Myc positively regulate ISKNV infection, while c-Myc is closely correlated...

  • Review
  • Open Access
10 Citations
5,072 Views
21 Pages

The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas

  • Mutaz Jamal Al-Khreisat,
  • Faezahtul Arbaeyah Hussain,
  • Ali Mahmoud Abdelfattah,
  • Alhomidi Almotiri,
  • Ola Mohammed Al-Sanabra and
  • Muhammad Farid Johan

4 June 2022

Lymphomas are heterogeneous malignant tumours of white blood cells characterised by the aberrant proliferation of mature lymphoid cells or their precursors. Lymphomas are classified into main types depending on the histopathologic evidence of biopsy...

  • Article
  • Open Access
725 Views
24 Pages

Epithelial AhR Suppresses Allergen-Induced Oxidative Stress and Senescence via c-Myc Regulation

  • Zhifeng Chen,
  • Wenjing Gu,
  • Rongjun Wan,
  • Yixiang Zeng,
  • Xudong Xiang,
  • Ruoyun Ouyang and
  • Peisong Gao

23 December 2025

Environmental allergens trigger epithelial reactive oxygen species (ROS) production and cellular senescence, contributing to airway inflammation. The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor responsive to environmental...

  • Article
  • Open Access
9 Citations
2,805 Views
13 Pages

miR193a-5p Mediated ZNF746 and c-Myc Signaling Axis Is Critically Involved in Morusin Induced Apoptosis in Colorectal Cancer Cells

  • Woon-Yi Park,
  • Hyo-Jung Lee,
  • Deok-Yong Sim,
  • Eunji Im,
  • Ji-Eon Park,
  • Chi-Hoon Ahn,
  • Bum-Sang Shim and
  • Sung-Hoon Kim

12 August 2021

Novel target therapy is on the spotlight for effective cancer therapy. Hence, in the present study, the underlying apoptotic mechanism of Morusin was explored in association with miR193a-5p mediated ZNF746/c-Myc signaling axis in colorectal cancer ce...

  • Article
  • Open Access
9 Citations
3,056 Views
15 Pages

7 October 2022

Timosaponin A3 (TA3), extracted from the rhizome of Anemarrhenaasphodeloides Bunge, has been reported to affect various diseases, such as cancer, Alzheimer’s disease, and allergies. However, the underlying molecular mechanisms and impacts are l...

  • Article
  • Open Access
35 Citations
5,264 Views
14 Pages

Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2

  • Ji Hoon Jung,
  • Hyo-Jung Lee,
  • Ju-Ha Kim,
  • Deok Yong Sim,
  • Eunji Im,
  • Sinae Kim,
  • Suhwan Chang and
  • Sung-Hoon Kim

16 April 2020

Though midline1 interacting protein 1 (MID1IP1) was known as one of the glucose-responsive genes regulated by carbohydrate response element binding protein (ChREBP), the underlying mechanisms for its oncogenic role were never explored. Thus, in the p...

  • Article
  • Open Access
1,594 Views
23 Pages

Galangin and 1′-Acetoxychavicol Acetate from Galangal (Alpinia galanga) Suppress Lymphoma Growth via c-Myc Downregulation and Apoptosis Induction

  • Sirinya Moakmamern,
  • Lapamas Rueankham,
  • Natsima Viriyaadhammaa,
  • Kittikawin Panyakham,
  • Natnicha Khakhai,
  • Pinyaphat Khamphikham,
  • Suwit Duangmano,
  • Siriporn Okonogi,
  • Sawitree Chiampanichayakul and
  • Songyot Anuchapreeda

21 August 2025

The c-Myc protein, a key regulator of cell proliferation, growth, and apoptosis in B-cell lymphocytes, is frequently dysregulated in Burkitt’s lymphoma. Zingiberaceae plants—galangal (Alpinia galanga), black turmeric (Curcuma aeroginosa),...

  • Article
  • Open Access
1 Citations
1,396 Views
16 Pages

Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc

  • Roberta Santarelli,
  • Claudia Di Dio,
  • Michele Di Crosta,
  • Paola Currà,
  • Roberta Gonnella and
  • Mara Cirone

22 July 2025

Curcumin-mediated anti-cancer properties have been correlated with the inhibition of oncogenic molecules such as mutp53 and c-Myc. Their targeting is therapeutically significant, as p53, following point mutations, can acquire oncogenic functions, and...

  • Article
  • Open Access
1,134 Views
16 Pages

Circaea mollis Siebold & Zucc. Induces Apoptosis in Colorectal Cancer Cells by Inhibiting c-Myc Through the Mediation of RPL5

  • So-Mi Park,
  • Nanyeong Kim,
  • Ye-Rin Park,
  • Seok Woo Kim,
  • Ji Hoon Jung,
  • Yun-Cheol Na,
  • Daeho Kwon,
  • Hyungsuk Kim and
  • Hyeung-Jin Jang

Colorectal cancer remains a significant global health concern. In this study, we investigated the anticancer potential of Circaea mollis Siebold & Zucc. (CS&Z), a traditional medicinal plant known for its anti-inflammatory, anti-arthritic, an...

  • Article
  • Open Access
6 Citations
2,527 Views
17 Pages

Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells

  • Ye-Rin Park,
  • Wona Jee,
  • So-Mi Park,
  • Seok-Woo Kim,
  • Ji-Hoon Jung,
  • Hyungsuk Kim,
  • Kwan-Il Kim and
  • Hyeung-Jin Jang

18 December 2023

Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and despite advances in treatment, survival rates are still low; therefore, the development of novel drugs is imperative. Acetylcorynoline (ACN) is derived from Corydalis ...

of 20